Search for: "Eva C Simmons"
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
9 Mar 2020, 1:21 pm
Biosimilar Markets [I entered in media res]· Eva Temkin, Acting Director for Policy, Office of Therapeutic Biologics and Biosimilars, CDER, FDA · Christine Simmon, Executive Director, Biosimilars Council, AAM: barriers to entry for biosimilars: exclusionary contracts, rebates, stakeholder misinformation. misinformation can include explicit and implicit, including policies such as naming conventions and the very existence of the interchangeable… [read post]
3 Feb 2019, 9:05 am
Keith C. [read post]